CCC
RNTX

Cable Car Capital’s Rein Therapeutics RNTX Stock Holding History

Cable Car Capital’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$546K Hold
420,000
– – 0.19% 74
2025
Q4 		$487K Hold
420,000
– – 0.02% 70
2025
Q3 		$481K Hold
420,000
– – 0.21% 49
2025
Q2 		$588K Hold
420,000
– – 0.19% 34
2025
Q1 		$743K Hold
420,000
– – 0.84% 30
2024
Q4 		$966K Hold
420,000
– – 0.04% 63
2024
Q3 		$1.49M Hold
420,000
– – 1.59% 20
2024
Q2 		$1.16M Buy
+420,000
New +$1.73M 1.23% 23

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Cable Car Capital's RNTX Position: Q1 2026 in Review

Cable Car Capital held its Rein Therapeutics (RNTX) position steady in Q1 2026 at 420,000 shares worth $546K. The position accounts for 0.19% of the portfolio, ranked #74.

Cable Car Capital first reported a position in RNTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.49M in Q3 2024. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Cable Car Capital held 420,000 shares of Rein Therapeutics worth $546K as of Q1 2026.
  • Cable Car Capital left its Rein Therapeutics share count unchanged in Q1 2026.
  • Rein Therapeutics made up 0.19% of Cable Car Capital's portfolio in Q1 2026, its #74 holding.
  • Cable Car Capital first reported a position in Rein Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Cable Car Capital's Rein Therapeutics position peaked at $1.49M in Q3 2024.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Cable Car Capital's 13F filing for Q1 2026, filed 15 May 2026.